Community/Retail

The Food and Drug Administration (FDA) and the generic drug manufacturing industry including representatives of generic pharmaceutical manufacturers, active pharmaceutical ingredient manufacturers and contract manufacturing organizations have reached agreement on a package of program enhancements and resource commitments to reauthorize the Generic Drug User Fee Amendments of 2012 (GDUFA), which are set to expire next year.

With the availability of Internet search functions, students often struggle to memorize large blocks of information in the unfamiliar language of generic and brand-name medications.